Open main menu
Home
Random
Donate
Recent changes
Special pages
Community portal
Preferences
About Stockhub
Disclaimers
Search
User menu
Talk
Contributions
Create account
Log in
Editing
C-Major
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Idea== <vimeo>466466654</vimeo> A needle-stick injury (NSI) occurs when a needle used on a patient cuts someone else’s skin. A global problem, over 2m people suffer a NSI every year and are at risk of contracting serious blood-borne viruses such as Hepatitis and HIV. The most effective existing solutions are auto-retracting syringes where stored energy is used to retract the needle as quickly and safely as possible. However, when the needle springs back, it can result in blood splatter, meaning the blood (and any viruses it contains) can spread easily to others. As such, these solutions are used only for injections and not for aspirating (taking blood). Since starting in 2018, C-Major has undertaken a number of user trials. Our “Controlled Helical Retraction Device” aims to be the first auto-retracting technology on the market for blood collection. The device contains a ‘helical track’ mechanism for controlled acceleration of the needle during retraction as well as a ‘sealed port’ to minimise splatter. This technology is fully patented in target markets and, upon securing regulatory approval, has a broad range of applications. With the safety syringe market expected to be worth $8.4bn by 2024, we are now raising funds to complete the design for manufacture and assembly process ahead of a Series A round in 2021.
Summary:
Please note that all contributions to Stockhub may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Stockhub:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)